Friday, August 24, 2018
Mayo Clinic Researchers to Study if Hands-Free Camera in Space Can Monitor Vital Signs

Astronauts intermittently monitor their vital signs in space for experiments, partly because continuous monitoring requires multiple contact points on the body and the use of cumbersome batteries. Now, researchers at Mayo Clinic’s Florida campus are studying a device to be launched into space that is designed to use a small, inexpensive camera fitted with specialized software. ..

Read More
Monday, July 09, 2018
Mayo Clinic Simulation Center Receives Top Accreditation

The Mayo Clinic J. Wayne and Delores Barr Weaver Simulation Center at Mayo Clinic's Florida campus has earned accreditation in teaching and education by the Society for Simulation in Healthcare in Washington, D.C. The center is one of only 100 in the world to be recognized as having the highest quality standards in health care simulation. ..

Read More
Wednesday, January 10, 2018
FDA clears way for Mayo Clinic to accelerate production of stem cells for clinical trials through automation

The FDA has agreed to allow Mayo Clinic to use an automated bioreactor-based stem cell production platform on its campus in Jacksonville, Florida. This enables the Mayo Clinic Center for Regenerative Medicine to produce cells from the bone marrow of a stem cell donor in quantities large enough to make several doses that can be used as treatments in clinical trials. ..

Read More
Saturday, December 09, 2017
Mayo Clinic: Study identifies barriers to transplant therapy to treat multiple myeloma among racial minority groups

A study by researchers at Mayo Clinic’s campus in Jacksonville, Florida has found that barriers to patients receiving stem cell therapy as part of their treatment for multiple myeloma include income, education, insurance status and access to care at an academic center or facility that treats a high volume of patients. ..

Read More
Thursday, November 02, 2017
Mayo Clinic researchers find brain tumors gain an edge by commandeering normal growth proteins

What makes some brain cancers so hard to treat? Researchers in the laboratory of Alfredo Quiñones-Hinojosa, M.D., chair of Neurologic Surgery on Mayo Clinic’s Florida campus, looked at devastating brain tumors known as chordomas to understand why those tumors are capable of growing so aggressively. In a study published online today in Cell Reports, they found the tumors do their dirty work by hijacking growth machinery that exists in stem cells. Stem cells—the undifferentiated cells capable of turning into any cell in the body—have two particular proteins that are activated when the body is first developing. These proteins are responsible for growing the body’s organs, but the proteins become inactive after the organs reach the appropriate size. However, chordomas manage to co-opt those proteins and use them to thrive. ..

Read More
Thursday, November 02, 2017
Mayo Clinic researchers to get closer look at the brain’s pathways in Alzheimer’s disease

Researchers have long known that genetics play a role in causing the dementia of Alzheimer’s disease, but genes, it turns out, are only part of the story. What’s come to light over the last several years is the incredible complexity of the disease, which involves not only genetic factors but also the vasculature of the brain. It’s not clear, however, what goes wrong within the cells of the brain’s blood vessels, how they accumulate clumps of toxic proteins, or how that process contributes to cognitive decline. A team of researchers on Mayo Clinic’s campus in Florida has received a grant of $3.5 million from the National Institute on Aging (NIA), of the National Institutes of Health, to better understand the interconnected genetic and vascular pathways involved in Alzheimer’s. ..

Read More
Tuesday, August 08, 2017
Sanford Burnham Prebys and Mayo Clinic Collaborators Awarded Multi-Year NIH Grant

A team of researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) at Lake Nona, Fla. and Mayo Clinic in Rochester, Minnesota have been awarded a three-year National Institutes of Health (NIH) grant which aims to identify molecules that could become new medicines to inhibit myocardial fibrosis.  ..

Read More
Monday, May 01, 2017
Mayo Clinic researchers develop new tumor-shrinking nanoparticle to fight cancer, prevent recurrence

A Mayo Clinic research team has developed a new type of cancer-fighting nanoparticle aimed at shrinking breast cancer tumors, while also preventing recurrence of the disease. In the study, published today in Nature Nanotechnology, mice that received an injection with the nanoparticle showed a 70 to 80 percent reduction in tumor size. Most significantly, mice treated with these nanoparticles showed resistance to future tumor recurrence, even when exposed to cancer cells a month later. ..

Read More
Wednesday, March 01, 2017
Mayo Clinic publishes genetic screen for Alzheimer’s in African-Americans

A Mayo Clinic research team has found a new gene mutation that may be a risk factor for late-onset Alzheimer’s disease in African-Americans. This is the first time this gene has been implicated in the development of this disease in this population.  ..

Read More
Monday, February 20, 2017
Blast off: Stem cells from Mayo Clinic physician’s lab launch into space

Consider it one physician’s giant leap for mankind. The latest rocket launch from NASA’s Kennedy Space Center in Cape Canaveral, Florida, included a payload of several samples of donated adult stem cells from a research laboratory at Mayo Clinic’s Florida campus. ..

Read More